(Total Views: 227)
Posted On: 11/17/2020 7:09:17 AM
Post# of 106881
$CURR CURE Pharmaceutical Closes $10 Million Financing
Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline -
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the "Notes"
. Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.
CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments.
https://finance.yahoo.com/news/cure-pharmaceu...00216.html
Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline -
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the "Notes"
. Axiom Capital Management, Inc. acted as the sole placement agent in the transaction. CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments.
https://finance.yahoo.com/news/cure-pharmaceu...00216.html
(0)
(0)
